Trial Profile

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT).

Status: Discontinued

Phase of Trial: Phase II/III

Latest Information Update: 10 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alteplase (Primary) ; Urokinase (Primary) ; Heparin
Indications Intracranial thrombosis
Focus Therapeutic Use
Acronyms TO-ACT; TOACT

Most Recent Events

11 Feb 2017 Planned End Date changed from 1 Jan 2018 to 1 Oct 2017.
11 Feb 2017 Status changed from recruiting to discontinued.
08 Nov 2011 New source identified and integrated (European Clinical Trials Database: EudraCT2010-020302-15).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com